|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3 Suppl
|
|
pubmed:dateCreated |
2003-5-13
|
|
pubmed:abstractText |
With the introduction of new immunosuppressive medicines, it has become possible to determine the extent to which nephrotoxic medicines contribute to CAN. The aim of this study is to compare the safety and efficacy of calcineurin inhibitor (CI) free immunosuppression in a prospective, randomized trial comparing sirolimus-mycophenolate mofetil (MMF)-prednisone to tacrolimus- MMF-prednisone.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
pubmed-author:CosioFF,
pubmed-author:GloorJJ,
pubmed-author:GriffinMM,
pubmed-author:IshitaniMM,
pubmed-author:KremersWW,
pubmed-author:LarsonT STS,
pubmed-author:LundWW,
pubmed-author:NybergSS,
pubmed-author:PrietoMM,
pubmed-author:SchwabTT,
pubmed-author:StegallM DMD,
pubmed-author:SterioffSS,
pubmed-author:TextorSS,
pubmed-author:VelosoDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
125S-127S
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12742483-Calcineurin,
pubmed-meshheading:12742483-Drug Therapy, Combination,
pubmed-meshheading:12742483-Follow-Up Studies,
pubmed-meshheading:12742483-Glomerular Filtration Rate,
pubmed-meshheading:12742483-Graft Rejection,
pubmed-meshheading:12742483-Humans,
pubmed-meshheading:12742483-Immunosuppressive Agents,
pubmed-meshheading:12742483-Kidney Transplantation,
pubmed-meshheading:12742483-Muromonab-CD3,
pubmed-meshheading:12742483-Mycophenolic Acid,
pubmed-meshheading:12742483-Prednisone,
pubmed-meshheading:12742483-Sirolimus,
pubmed-meshheading:12742483-Time Factors,
pubmed-meshheading:12742483-Transplantation, Homologous
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Kidney transplantation without calcineurin inhibitors using sirolimus.
|
|
pubmed:affiliation |
Department of Surgery, Mayo Foundation and Clinic, Rochester, Minnesota, USA. Stegall.mark@mayo.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
